Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer
AbstractLung cancer is the leading cause of deaths resulting from cancer owing to late diagnosis and limited treatment intervention. MicroRNAs are short, non-coding RNA molecules that regulate gene expression post-transcriptionally by translational repression or target messenger RNA degradation. Accumulating evidence suggests various roles for microRNAs, including development and progression of lung cancers. Because microRNAs are degraded to a much lesser extent in formalin-fixed paraffin-embedded specimens and are present not only in tumor tissues but also in body fluids, there is an increased potential in microRNA analyses for cancer research. In this review, recent studies of microRNA are introduced and briefly summarized, with a focus on the association of microRNAs with histological subtypes, genetic driver alterations, therapeutically-targeted molecules, and carcinogens. The reported circulating microRNA signature for the early detection of lung cancer and the implications of microRNAs as the modulators of tumor immune response are also introduced. View Full-Text
Share & Cite This Article
Inamura, K. Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer. Cancers 2017, 9, 49.
Inamura K. Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer. Cancers. 2017; 9(5):49.Chicago/Turabian Style
Inamura, Kentaro. 2017. "Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer." Cancers 9, no. 5: 49.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.